Field evaluation of the gag-based heteroduplex mobility assay for genetic subtyping of circulating recombinant forms of human immunodeficiency virus type 1 in Abidjan, Côte d'Ivoire

Journal of Clinical Microbiology

Volumn 41, Issue 7, 2003, Pages 3056-3059

  Sawadogo, Souleymane ^a   Adjé Touré, Christiane ^a   Bilé, Celestin E ^a   Ekpini, Rene E A ^a   Chorba, Terence ^a,b   Nkengasong, John N ^a,b  

^a Project RETRO CI Abidjan   (Côte d’Ivoire)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EVALUATION; FEMALE; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; VIRUS STRAIN; VIRUS TYPING;

COTE D'IVOIRE; DNA, VIRAL; GENES, GAG; HETERODUPLEX ANALYSIS; HIV INFECTIONS; HIV-1; HUMANS; RECOMBINATION, GENETIC; RNA, VIRAL; VARIATION (GENETICS);

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0038168323     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.7.3056-3059.2003     Document Type: Article

References (24)

1. Adje, C., R. Cheingsong, H. T. Roels, C. Maurice, G. Djomand, W. Verbiest, K. Hertogs, B. Larder, B. Monga, M. Peeters, S. Eholie, E. Bissagnene, M. Coulibaly, R. Respess, S. Z. Wiktor, T. Chorba, and J. N. Nkengasong for the UNAIDS HIV Drug Access Initiative, Abidjan, Côte d'Ivoire. 2001. High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote d'Ivoire. J. Acquir. Immune Defic. Syndr. 26:501-506.
2. Agwale, S. M., K. E. Robbins, L. Odama, A. Saekhou, C. Zeh, A. Edubio, O. M. Njoku, N. Sani-Gwarzo, M. F. Gboun, F. Gao, M. Reitz, D. Hone, T. M. Folks, D. Pieniazek, C. Wambebe, and M. L. Kalish. 2001. Development of an env gp41-based heteroduplex mobility assay for rapid human immunodeficiency virus type 1 subtyping. J. Clin. Microbiol. 39:2110-2114.
3. AIDS. 2001. Approaches to the development of broadly protective HIV vaccines: challenges posed by the genetic, biological and antigenic variability of HIV-1. Report from a meeting of the WHO-UNAIDS Vaccine Advisory Committee, Geneva, 21-23 February 2000. AIDS 15:W1-W25.
4. Baldrich-Rubio, E., S. Anagonou, K. Stirrups, E. Lafia, D. Candotti, H. Lee, and J. P. Allain. 2001. A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa. J. Gen. Virol. 82:1095-1106.
5. Barlow, K. L., I. D. Tatt, P. A. Cane, D. Pillay, and J. P. Clewley. 2001. Recombinant strains of HIV type 1 in the United Kingdom. AIDS Res. Hum. Retrovir. 17:467-474.
6. Cham, F., L. Heyndrickx, W. Janssens, K. Vereecken, K. De Houwer, S. Coppens, G. Van der Auwera, H. Whittle, and G. Van der Groen. 2000. Development of a one-tube multiplex reverse transcriptase-polymerase chain reaction assay for the simultaneous amplification of HIV type 1 group M gag and env heteroduplex mobility assay fragments. AIDS Res. Hum. Retrovir. 16:1503-1505.
7. Cham, F., L. Heyndrickx, W. Janssens, G. Van der Auwera, K. Vereecken, K. De Houwer, S. Coppens, H. Whittle, and G. Van der Groen. 2000. Study of HIV type 1 gag/env variability in The Gambia, using a multiplex DNA polymerase chain reaction. AIDS Res. Hum. Retrovir. 16:1915-1919.
8. Delwart, E. L., B. Herring, A. G. Rodrigo, and J. I. Mullins. 1995. Genetic subtyping of human immunodeficiency virus using a heteroduplex mobility assay. PCR Methods Appl. 4:S202-S216.
9. Heyndrickx, L., W. Janssens, L. Zekeng, R. Musonda, S. Anagonou, G. van der Auwera, S. Coppens, K. Vereecken, K. De Witte, R. van Rampelbergh, M. Kahindo, L. Morison, F. E. McCutchan, J. K. Carr, J. Albert, M. Essex, J. Goudsmit, B. Asjo, M. Salminen, A. Buve, Study Group on Heterogeneity of HIV Epidemics in African Cities, and G. van der Groen. 2000. Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. J. Virol. 74:363-370.
10. Koulinska, I. N., T. Ndung'u, D. Mwakagile, G. Msamanga, C. Kagoma, W. Fawzi, M. Essex, and B. Renjifo. 2001. A new human immunodeficiency virus type 1 circulating recombinant form from Tanzania. AIDS Res. Hum. Retrovir. 17:423-431.
11. Kusagawa, S., Y. Takebe, R. Yang, K. Motomura, W. Ampofo, J. Brandful, Y. Koyanagi, N. Yamamoto, T. Sata, K. Ishikawa, Y. Nagai, and M. Tatsumi. 2001. Isolation and characterization of a full-length molecular DNA clone of Ghanaian HIV type 1 intersubtype A/G recombinant CRF02 AG, which is replication competent in a restricted host range. AIDS Res. Hum. Retrovir. 17:649-655.
12. Montavon, C., F. Bibollet-Ruche, D. Robertson, B. Koumare, C. Mulanga, E. Esu-Williams, C. Toure, S. Mboup, E. Saman, E. Delaporte, and M. Peeters. 1999. The identification of a complex A/G/I/J recombinant HIV type 1 virus in various West African countries. AIDS Res. Hum. Retrovir. 15:1707-1712.
13. Montavon, C., C. Toure-Kane, F. Liegeois, E. Mpoudi, A. Bourgeois, L. Vergne, J. L. Perret, A. Boumah, E. Saman, S. Mboup, E. Delaporte, and M. Peeters. 2000. Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. J. Acquir. Immune Defic. Syndr. 23:363-374.
14. Nkengasong, J. N., C. Maurice, S. Koblavi, M. Kalou, D. Yavo, M. Maran, C. Bile, K. Nguessan, J. Kouadio, S. Bony, S. Z. Wiktor, and A. E. Greenberg. 1999. Evaluation of HIV serial and parallel serologic testing algorithms in Abidjan, Côte d'Ivoire. AIDS 13:109-117.
15. Nkengasong, J. N., C.-C. Luo, L. Abouya, D. Pieniazek, C. Maurice, M. Sassan-Morokro, D. Ellenberger, D. J. Hu, C.-P. Pau, T. Dobbs, R. Respess, D. Coulibaly, I.-M. Coulibaly, S. Z. Wiktor, A. E. Greenberg, and M. Rayfield. 2000. Distribution of HIV-1 subtypes among HIV-1 seropositive patients in the interior of Cote d'Ivoire. J. Acquir. Immune Defic. Syndr. 23:430-436.
16. Oelrich, R. B., C. Workman, T. Laukkanen, F. E. McCntchan, and N. J. Deacon. 1998. A novel subtype A/G/J recombinant full-length HIV type 1 genome from Burkina Faso. AIDS Res. Hum. Retrovir. 14:1495-1500.
17. Pasquier, C., N. Millot, R. Njouom, K. Sandres, M. Cazabat, J. Puel, and J. Izopet. 2001. HIV-1 subtyping using phylogenetic analysis of pol gene sequences. J. Virol. Methods 94:45-54.
18. Peeters, M., F. Liegeois, F. Bibollet-Ruche, D. Patrel, J.-L. Perret, N. Vidal, E. Esu-Williams, S. Mboup, E. Mpoudi, N. Nzila, and E. Delaporte. 1998. Subtype-specific polymerase chain reaction for the identification of HIV-1 genetic subtypes circulating in Africa. AIDS 12:671-673.
19. Robertson, D. L., J. P. Anderson, J. A. Bradac, J. K. Carr, B. Foley, R. K. Funkhouser, F. Gao, B. H. Hahn, M. L. Kalish, C. Kuiken, G. H. Learn, T. Leitner, F. McCutchan, S. Osmanov, M. Peeters, D. Pieniazek, M. Salminen, P. M. Sharp, S. Wolinsky, and B. Korber. 1999. HIV-1 nomenclature proposal. A reference guide to HIV-1 classification. In B. Korber, C. Brander, B. F. Haynes, J. P. Moore, R. Koup, B. D. Walker, and D. I. Watkins (ed.), HIV molecular immunology database 1999. Los Alamos National Laboratory, Los Alamos, N.Mex. [Online.] http://hiv-web.lanl.gov/content/hiv-db /reviews/nomenclature/Nomen.html.
20. Subbarao, S., S. Vanichseni, D. J. Hu, D. Kitayaporn, K. Choopanya, S. Raktham, N. L. Young, C. Wasi, R. Sutthent, C.-C. Luo, A. Ramos, and T. D. Mastro. 2000. Genetic characterization of HIV-1 subtype E and B strains from a prospective cohort of injecting drug users in Bangkok, Thailand. AIDS Res. Hum. Retrovir. 16:699-707.
21. Tatt, I. D., K. L. Barlow, and J. P. Clewley. 2000. A gag gene heteroduplex mobility assay for subtyping HIV-1. J. Virol. Methods 87:41-51.
22. Thomson, M. M., E. Delgado, N. Majon, A. Ocampo, M. L. Villahermosa, A. Marino, I. Herrero, M. T. Cuevas, E. Vasquez-de Parga, L. Perez-Alvarez, L. Medrano, J. A. Taboada, R. Najera, and the Spanish Group for Antiretroviral Studies in Galicia. 2001. HIV-1 genetic diversity in Galicia, Spain: BG intersubtype recombinant viruses circulating among injecting drug users. AIDS 15:509-516.
23. Vidal, N., M. Peeters, C. Mulanga-Kabeya, N. Nzilambi, D. Robertson, W. Ilunga, H. Sema, K. Tshimanga, B. Bongo, and E. Delaporte. 2000. Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in central Africa. J. Virol. 74:10498-10507.
24. Weidle, P. J., T. D. Mastro, A. D. Grant, J. N. Nkengasong, and D. Macharia. 2002. HIV/AIDS treatment and HIV vaccines for Africa. Lancet 359:2261-2267.